NH NongwoobioNH농우바이오
054050 · KOSDAQ · ₩054050 · NH농우바이오
₩6,650▼ ₩30 (0.45%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 48.2% | 49.0% | 49.7% | 48.7% | 47.2% | 47.6% |
| Operating margin | 6.7% | 8.6% | 7.7% | 6.6% | 7.5% | 5.1% |
| Net margin | 12.0% | 7.7% | 7.5% | 7.6% | 6.7% | 5.2% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +1.1% | +9.8% | +6.5% | −7.1% | +10.1% | — |
| Operating income growth | −21.2% | +22.9% | +24.1% | −18.8% | +61.4% | — |
| Net income growth | +57.2% | +12.6% | +5.7% | +5.1% | +41.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 6.8% | 4.5% | 4.1% | 4.1% | 4.0% | 2.9% |
| Return on assets | 5.4% | 3.5% | 3.3% | 3.2% | 3.1% | 2.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 26.3% | 26.8% | 26.4% | 821.1% | 144.9% | 27.6% |
| Net debt to equity | −4.9% | −9.4% | −7.2% | −173.2% | 8.8% | 2.4% |
| Current ratio | 385.4% | 334.4% | 384.6% | 326.4% | 275.8% | 291.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: NH Nongwoobio / NH농우바이오 / 054050 / KRX:054050
Source: KRX statistical information